Filter
1498
Text search:
Laboratory
diagnostics
Featured
198
393
Language
Document type
765
250
246
92
67
29
19
11
6
4
4
3
2
Countries / Regions
64
53
44
37
35
33
26
25
24
23
23
23
23
22
22
21
21
21
19
16
14
13
13
12
11
11
11
10
10
10
9
9
8
7
7
7
6
6
6
6
5
5
5
5
5
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
479
178
89
65
28
21
10
1
1
Toolboxes
255
179
165
112
81
73
42
27
26
21
18
14
12
12
11
10
8
8
7
6
4
4
Addresses the problematic to provide good laboratory services because of the quality and constancy of supply of laboratory reagents.
Комплект учебных материалов по Xpert MTB/RIF
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to nee
...
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
COVID-19 Diagnostics
recommended
ASLM strives to keep laboratory networks in Africa connected and informed of diagnostic tools, techniques, procedures and advancements related to COVID-19 testing with interactive training and information sessions using the Extended Community Health
...
OBJETIVO DE LA GUÍA
Describir los lineamientos técnicos de la vigilancia de tuberculosis por el laboratorio, así como los
procesos de obtención, recolección, procesamiento, transporte y conservación de muestras, y las
funciones que se realizan y articulan por todos los integra
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associa
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will
...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
The handbook Global edition
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых
...
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification test
...
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
